AI assistant
Sending…
PMV Pharmaceuticals, Inc. — Director's Dealing 2025
Mar 5, 2025
34350_dirs_2025-03-05_ba01ffb7-891e-4806-8445-16ff7c5a250b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PMV Pharmaceuticals, Inc. (PMVP)
CIK: 0001699382
Period of Report: 2025-03-03
Reporting Person: Carulli Michael (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-03-03 | Employee Stock Option (right to buy) | $1.32 | A | 265000 | Acquired | 2035-03-03 | Common Stock (265000) | Direct |
Footnotes
F1: Shares subject to the option vest in 48 equal monthly installments beginning on April 3, 2025.
More from PMV Pharmaceuticals, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 9
Interim / Quarterly Report
2025
Nov 12
Regulatory Filings
2025
Nov 12
Major Shareholding Notification
2025
Nov 12
Director's Dealing
2025
Oct 29